MedMira Inc. (TSXV:MIR)
Canada · Delayed Price · Currency is CAD 0.0650
0.00 (0.00%)
At close: Mar 19, 2026
MedMira Market Cap
MedMira has a market cap or net worth of CAD 45.33 million as of March 20, 2026. Its market cap has decreased by -41.27% in one year.
Market Cap
45.33M
Enterprise Value
62.41M
Revenue
232.99K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since June 30, 2000, MedMira's market cap has decreased from 81.66M to 45.33M, a decrease of -44.49%. That is a compound annual growth rate of -2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 45.33M | -0.61% |
| Dec 31, 2025 | 45.61M | -31.58% |
| Dec 31, 2024 | 66.66M | -13.11% |
| Dec 29, 2023 | 76.72M | 37.50% |
| Dec 30, 2022 | 55.80M | -60.00% |
| Dec 31, 2021 | 139.49M | -13.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 58.87M |
| Medicenna Therapeutics | 58.39M |
| Sernova Biotherapeutics | 52.16M |
| Defence Therapeutics | 43.09M |
| BriaCell Therapeutics | 41.33M |
| Resverlogix | 34.78M |